BOB WODECKI MD NPI 1649270190

NPI Details

Bob Wodecki, MD is a rheumatology internal medicine in Statesville, NC with 40 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Bob Wodecki, MD NPI is 1649270190. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY
Graduation Year:1986

The provider's business location address is:

293 OLD MOCKSVILLE ROAD
STATESVILLE, NC
ZIP 28625-903
Phone: (704) 872-8711
Fax: (704) 872-5866

The NPI 1649270190 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg (HCPCS:J7332)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Injection, cetirizine hydrochloride, 0.5 mg (HCPCS:J1201)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• X-ray of wrist, minimum of 3 views (HCPCS:73110)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• Vitamin d-3 level (HCPCS:82306)
• Tuberculosis test, enumeration of t-cells (HCPCS:86481)
• X-ray of foot, minimum of 3 views (HCPCS:73630)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• X-ray of ankle, 2 views (HCPCS:73600)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• X-ray of chest, 2 views (HCPCS:71046)
• X-ray of foot, 2 views (HCPCS:73620)
• X-ray of wrist, 2 views (HCPCS:73100)
• X-ray of hand, 2 views (HCPCS:73120)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of influenza virus vaccine (HCPCS:G0008)
• X-ray of both hips, 2 views (HCPCS:73521)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• X-ray of upper spine, 4-5 views (HCPCS:72050)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Rheumatoid factor level (HCPCS:86431)
• Screening test for autoimmune disorder (HCPCS:86038)
• X-ray of joint between lower spine and hip bone, 1-2 views (HCPCS:72200)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Measurement of dna antibody, single stranded (HCPCS:86226)
• Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
• Complete ultrasound scan of joint (HCPCS:76881)
• X-ray of knee, 3 views (HCPCS:73562)
• Injection into tendon or ligament (HCPCS:20550)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Blood viscosity measurement (HCPCS:85810)
• X-ray of elbow, 2 views (HCPCS:73070)
• X-ray of middle spine, 2 views (HCPCS:72070)
• Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)

The enumeration date for this NPI number is 7/27/2005 and was last updated on 1/8/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.